Spartan Bioscience Announces First Point-of-Care DNA Testing System for Personalized Medicine  
8/10/2010 8:23:09 AM

OTTAWA, Ontario--(BUSINESS WIRE)--Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced the availability of the Spartan RX, the first complete sample-to-result, point-of-care DNA testing system for personalized medicine. The non-invasive and easy-to-use system provides automated results in one hour, enabling physicians to tailor treatments based on a patient’s genotype faster than ever before.